Panos Argiras is an accomplished executive specializing in cell and gene therapy manufacturing and operations, with a proven history of steering complex programs from early pre-clinical stages through to commercialization. As a versatile leader experienced in cross-functional collaboration, Panos manages end-to-end CMC activities, optimizes supply chains, and mitigates risks across clinical development and commercial launch. His expertise ensures robust CMC strategies, seamless tech transfers, and the highest standards of global regulatory compliance to deliver life-changing treatments to patients.